4-butyrolactone has been researched along with preclamol in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (81.82) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekman, A; Eriksson, E | 1 |
Ekman, A; Eriksson, E; Quiding, M | 1 |
Bohmaker, K; Friedhoff, AJ; Goldstein, M; Meller, E; Namba, Y | 1 |
Andersson, B; Eriksson, E; Hjorth, S | 1 |
Andersson, B; Carlsson, A; Hjorth, S; Svensson, K; Wikström, H | 1 |
Carlsson, A; Carlsson, M; Eriksson, E; Nilsson, C | 1 |
Howard, HR; Kelly, TR; Koe, BK; Sarges, R | 1 |
Carlsson, A; Clark, D; Hjorth, S | 1 |
Dijkstra, D; Horn, AS; Houwing, HA; Van Oene, JC | 1 |
Haubrich, DR; Martin, GE; Williams, M | 2 |
11 other study(ies) available for 4-butyrolactone and preclamol
Article | Year |
---|---|
Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on the prolactin suppression induced by a series of full and partial dopamine D2 receptor agonists in male rats.
Topics: 4-Butyrolactone; Adrenergic alpha-Antagonists; Animals; Apomorphine; Dopamine Agents; Ergolines; Levodopa; Male; Piperidines; Prolactin; Quinolines; Rats; Rats, Sprague-Dawley | 1992 |
Effects of the two partial D2 agonists (+)- and (-)-3-PPP on prolactin release in EEDQ treated male rats.
Topics: 4-Butyrolactone; Animals; Brain; Dopamine Agents; Male; Piperidines; Prolactin; Quinolines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Reference Values | 1991 |
Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
Topics: 4-Butyrolactone; Adrenergic alpha-Antagonists; Animals; Apomorphine; Corpus Striatum; Dihydroxyphenylalanine; Homeostasis; Hydrazines; Levodopa; Male; Piperidines; Quinolines; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1987 |
Stereoselective inhibition of prolactin secretion by (-)-HW-165, a novel 3-PPP congener; further support for similarities between central DA autoreceptors and pituitary lactotroph DA receptors.
Topics: 4-Butyrolactone; Animals; Apomorphine; Depression, Chemical; Male; Phenanthrenes; Piperidines; Pituitary Gland; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Stereoisomerism | 1986 |
Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP.
Topics: 4-Butyrolactone; Animals; Behavior, Animal; Catecholamines; Corpus Striatum; Limbic System; Male; Motor Activity; Phenanthrenes; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Stereoisomerism | 1986 |
Sexually differentiated actions of 3-PPP enantiomers on prolactin secretion.
Topics: 4-Butyrolactone; Animals; Female; Furans; Male; Piperidines; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sex Factors; Stereoisomerism | 1986 |
Synthesis and dopamine autoreceptor activity of a 5-(methylmercapto)methyl-substituted derivative of (+/-)-3-PPP (3-(3-hydroxyphenyl)-1-n-propylpiperidine).
Topics: 4-Butyrolactone; Animals; Chemical Phenomena; Chemistry; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Mice; Piperidines; Rats; Receptors, Dopamine; Structure-Activity Relationship | 1985 |
(+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis.
Topics: 4-Butyrolactone; Animals; Apomorphine; Corpus Striatum; Dopamine; Isomerism; Male; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Neurotransmitter | 1984 |
trans-N-n-Propyl-7-hydroxy-octahydrobenzo(f)quinoline, a rigid 3-PPP analogue with greater potency but lack of selectivity for dopamine autoreceptors.
Topics: 4-Butyrolactone; Animals; Corpus Striatum; Dihydroxyphenylalanine; Female; Hydroxyquinolines; Male; Mice; Motor Activity; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine | 1983 |
A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.
Topics: 4-Butyrolactone; Animals; Apomorphine; Cell Membrane; Corpus Striatum; Female; Humans; Hydroxydopamines; Naphthalenes; Oxidopamine; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Tetrahydronaphthalenes | 1982 |
Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
Topics: 4-Butyrolactone; Animals; Apomorphine; Brain; Dogs; Dopamine; Female; Male; Mice; Motor Activity; Naphthalenes; Piperidines; Rats; Receptors, Dopamine; Tetrahydronaphthalenes | 1981 |